清肺定喘泻热方联合中医个体化肺康复治疗慢性阻塞性肺疾病急性加重伴呼吸衰竭临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R248;R563

基金项目:

浙江省医药卫生科技计划项目(2015KYA242)


Clinical Study on Qingfei Dingchuan Xiere Prescription Combined with Personalized Lung Rehabilitation Therapy of Chinese Medicine for Acute Exacerbation of Chronic Obstructive Pulmonary Disease Complicated with Respiratory Failure
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察清肺定喘泻热方联合中医个体化肺康复治疗慢性阻塞性肺疾病急性加重(AECOPD) 伴呼吸衰竭的临床疗效。方法:选择84 例AECOPD 伴呼吸衰竭患者,按随机双盲法分为观察组和对照组各42 例。对照组给予常规西医治疗,观察组在对照组的基础上给予清肺定喘泻热方联合中医个体化肺康复治疗。比较2 组临床治疗效果、中医症状积分、肺功能指标[用力肺活量(FVC)、第1 秒用力呼气容积(FEV1)、FEV1/FVC] 及血气指标[二氧化碳分压(PaCO2)、动脉血氧分压(PaO2)]水平。结果:观察组总有效率为88.10%,对照组为69.05%,2 组比较,差异有统计学意义(P<0.05)。治疗前,2 组咳嗽、咳痰、呼吸困难等症状积分比较,差异无统计学意义(P>0.05);治疗后,2 组咳嗽、咳痰、呼吸困难积分均较治疗前降低(P<0.05),且观察组各项症状积分均低于对照组(P<0.05)。治疗前,2 组FVC、FEV1、FEV1/FVC 水平比较,差异无统计学意义(P>0.05);治疗后,2 组FVC、FEV1、FEV1/FVC 水平均较治疗前升高(P<0.05),且观察组上述指标均高于对照组(P<0.05)。治疗前,2 组血气指标PaCO2、PaO2 水平比较,差异无统计学意义(P>0.05);治疗后,2 组PaCO2、PaO2 水平均较治疗前改善(P<0.05),且观察组上述指标改善较对照组更显著(P<0.05)。结论:清肺定喘泻热方联合中医个体化肺康复治疗AECOPD 伴呼吸衰竭效果显著,可快速减轻患者临床症状,改善血气指标,增强肺功能。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Qingfei Dingchuan Xiere prescription combined with personalized lung rehabilitation therapy of Chinese medicine for acute exacerbation of chronic obstructive pulmonary disease(AECOPD) complicated with respiratory failure. Methods: A total of 84 cases of patients with AECOPD complicated with respiratory failure were divided into the observation group and the control group by randomized double-blind method,with 42 cases in each group. The control group was treated with routine western medicine,and the observation group was additionally treated with Qingre Dingchuan Xiere prescription combined with personalized lung rehabilitation therapy of Chinese medicine based on the treatment of the control group. Clinical effects, Chinese medicine symptom scores, indexes of the lung function [forced vital capacity(FVC), forced expiratory volume in one second(FEV1), FEV1/FVC], and indexes of blood gas[partial pressure of carbon dioxide(PaCO2), partial pressure of oxygen(PaO2) of artery] were compared between the two groups. Results: The total effective rate was 88.10% in the observation group, and 69.05% in the control group, the difference being significant(P<0.05). Before treatment,there was no significant difference being found in the comparison of symptom scores of cough, expectoration, and dyspnea between the two groups(P>0.05); after treatment, the above symptom scores in the two groups were decreased when compared with those before treatment(P<0.05), and each score in the observation group was lower than that in the control group(P<0.05). Before treatment,there was no significant difference being found in the comparison of the levels of FVC, FEV1, and FEV1/FVC between the two groups(P>0.05); after treatment, levels of FVC, FEV1, and FEV1/FVC in the two groups were increased when compared with those before treatment(P<0.05), and each index in the observation group was higher than that in the control group(P<0.05). Before treatment,there was no significant difference being found in the comparison of blood gas indexes including PaCO2 and PaO2 between the two groups(P>0.05);after treatment,the above two levels in the two groups were improved when compared with those before treatment(P<0.05),and the improvement of each index in the observation group was more significant than that in the control group(P<0.05). Conclusion: In the treatment of AECOPD complicated with respiratory failure, Qingfei Dingchuan Xiere prescription combined with personalized lung rehabilitation therapy of Chinese medicine has a significant effect,which can quickly relieve clinical symptoms,improve indexes of blood gas,and strengthen the lung function.

    参考文献
    相似文献
    引证文献
引用本文

叶丽君,朱夏玲.清肺定喘泻热方联合中医个体化肺康复治疗慢性阻塞性肺疾病急性加重伴呼吸衰竭临床研究[J].新中医,2021,53(24):184-187

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-12-27
  • 出版日期: